Autism

Latest News

Yamo enrolls final patient of phase 2 study of L1-79 to treat symptoms of ASD | Image Credit: © Dzmitry - © Dzmitry - stock.adobe.com.
Yamo enrolls final patient of phase 2 study of L1-79 to treat symptoms of ASD

November 29th 2023

Yamo Pharmaceuticals has initiated a phase 3 readiness program for L1-79, following the enrollment of its final patient in a phase 2 study evaluating the autism spectrum disorder (ASD) treatment for patients aged 2 to 21 years.

Discussing software that helps track progress after an autism diagnosis
Discussing software that helps track progress after an autism diagnosis

October 27th 2023

You may not need a specialist to diagnose ASD | Image Credit: © Contemporary Pediatrics - © Contemporary Pediatrics - stock.adobe.com.
You may not need a specialist to diagnose ASD

October 3rd 2023

Contemporary Pediatrics week in review: Tool to aid in autism diagnosis, increased RSV activity, and more | Image Credit: © Artur - © Artur - stock.adobe.com.
Contemporary Pediatrics week in review: Tool to aid in autism diagnosis, increased RSV activity, and more

September 8th 2023

FDA-cleared tool could assist in diagnosing autism
FDA-cleared tool could assist in diagnosing autism

September 6th 2023

Video Interviews
Podcasts
Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Navigating a New Era of Food Allergy Management

Register Now!

FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency

View More

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

More News

© 2023 MJH Life Sciences

All rights reserved.